# 11C-acetate for Treatment Response After Radiotherapy for HCC

> **NCT02549755** · PHASE2 · TERMINATED · sponsor: **Justin Sims** · enrollment: 1 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** 11C-Acetate

## Key facts

- **NCT ID:** NCT02549755
- **Lead sponsor:** Justin Sims
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2017-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549755, "11C-acetate for Treatment Response After Radiotherapy for HCC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02549755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*